GlaxoSmithKline - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : GlaxoSmithKline

Top of Directory » All Categories » by Company » GlaxoSmithKline



  • Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

    Conditions:   Influenza A Virus, H1N1 Subtype;   Influenza B Virus;   Influenza, Human;   Influenza, Seasonal
    Intervention:   Drug: zanamivir aqueous solution
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Effect of SRT2104 on Endotoxin-induced Inflammation

    Condition:   Sepsis
    Interventions:   Drug: SRT2104;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting

    Conditions:   Chronic Bronchitis;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
    Intervention:   Other: Non-Interventional
    Sponsor:   GlaxoSmithKline
    Completed - verified November 2009
  • A Study of GSK573719 in Healthy Japanese Male Subjects

    Condition:   Healthy Volunteer
    Interventions:   Drug: Placebo;   Drug: GSK573719
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

    Condition:   Influenza Infection
    Interventions:   Biological: GSK pandemic vaccine GSK2340269A;   Biological: GSK pandemic vaccine GSK2340272A
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Treximet Early Intervention Adolescent Migraine

    Condition:   Adolescent Migraine
    Intervention:   Drug: Treximet
    Sponsors:   Premiere Research Institute;   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphysims

    Condition:   Acute Asthma
    Intervention:  
    Sponsors:   MetroHealth Medical Center;   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

    Condition:   Influenza
    Intervention:   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: GSK239512;   Drug: Placebo;   Drug: d-amphetamine
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: GSK239512;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease

    Condition:   Patients With Nasal Polyps
    Interventions:   Drug: fluticasone furoate;   Other: placebo
    Sponsors:   Johns Hopkins University;   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

    Condition:   Lymphoma, Large-Cell, Diffuse
    Interventions:   Drug: RITUXIMAB + DHAP;   Drug: RITUXIMAB + DVD;   Drug: OFATUMUMAB + DVD;   Drug: OFATUMUMAB + DHAP
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

    Conditions:   Breast Cancer;   Lung Cancer;   Colon Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Kidney Cancer;   Sarcoma;   Hepatocellular Cancer
    Interventions:   Drug: Pazopanib;   Drug: Pazopanib;   Drug: Ixabepilone;   Drug: Ixabepilone;   Drug: Ixabepilone
    Sponsors:   Masonic Cancer Center, University of Minnesota;   GlaxoSmithKline;   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

    Conditions:   Hypertriglyceridemia;   HIV Infection
    Interventions:   Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
    Sponsors:   Felizarta, Franco, M.D.;   GlaxoSmithKline
    Recruiting - verified November 2009
  • A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: GSK1362885;   Drug: GSK1362885
    Sponsor:   GlaxoSmithKline
    Active, not recruiting - verified November 2009
  • Lapatinib in Combination With Vinorelbine

    Conditions:   Cancer;   Neoplasms, Breast
    Interventions:   Drug: Lapatinib;   Drug: Vinorelbine;   Drug: Capecitabine
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • AVODART® Alopecia Post-marketing Surveillance (PMS)

    Condition:   Alopecia
    Intervention:   Drug: AVODAR®
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Clinical Trial to Compare the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine to a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

    Condition:   HIV Infections
    Interventions:   Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
    Sponsors:   French National Agency for Research on AIDS and Viral Hepatitis;   GlaxoSmithKline
    Active, not recruiting - verified November 2009
  • Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

    Condition:   Influenza Infection
    Interventions:   Biological: Prevenar;   Biological: GSK2340272A GSK Biologicals' investigational influenza pandemic vaccine;   Biological: InfanrixTM-IPV/Hib
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Effect of Veramyst and Olopadatine 0.2% Opthalmic Solution on Allergy Symptoms

    Condition:   Seasonal Allergic Rhinitis
    Interventions:   Drug: Veramyst /Artificial tears;   Drug: Veramyst / Artificial tears lubricant eye drops;   Drug: Veramyst nasal spray and Olopatadine eye drops;   Other: Veramyst placebo and Olopatadine0.2% eye drops
    Sponsors:   University of Chicago;   GlaxoSmithKline
    Recruiting - verified November 2009
  • Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

    Condition:   Influenza Infection
    Intervention:   Biological: GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)
    Sponsor:   GlaxoSmithKline
    Active, not recruiting - verified November 2009
  • Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects

    Condition:   Asthma
    Intervention:   Drug: fluticasone furoate
    Sponsor:   GlaxoSmithKline
    Recruiting - verified October 2009
  • Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects

    Condition:   Healthy Volunteer
    Intervention:   Drug: Paroxetine CR and Paroxetine IR
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

    Conditions:   Haemophilus Influenzae Type B Related Disease;   Pneumonia;   Meningitis;   Cellulitis;   Osteomyelitis;   Epiglottis
    Interventions:   Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108);   Biological: ActHIBTM;   Biological: PentacelTM;   Biological: PediarixTM;   Biological: PrevnarTM;   Biological: RotarixTM;   Biological: EngerixTM-B;   Biological: InfanrixTM
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With TwinrixTM Adult

    Conditions:   Hepatitis A;   Hepatitis B
    Interventions:   Procedure: Blood sampling;   Biological: Havrix;   Biological: EngerixTM-B
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • A Post-marketing Surveilance to Monitor the Safety of AVAMYS® NS

    Condition:   Rhinitis
    Intervention:   Drug: administration of Avamys NS
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

    Conditions:   Acute Coronary Syndrome;   Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease
    Interventions:   Drug: Darapladib 160 mg;   Drug: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

    Condition:   Asthma
    Intervention:   Biological: Mepolizumab (treatment) - Severe asthma
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified November 2009
  • Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma

    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Gliosarcoma
    Intervention:   Drug: Avastin in Combination with Radiation and Temozolomide followed by Avastin, Temozolomide, and Topotecan
    Sponsors:   Duke University;   Genentech;   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Lenalidomide and Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL)

    Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
    Interventions:   Drug: Lenalidomide;   Drug: Ofatumumab
    Sponsors:   M.D. Anderson Cancer Center;   GlaxoSmithKline;   Celgene Corporation
    Not yet recruiting - verified October 2009
  • Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients

    Condition:   Cardiovascular Disease
    Interventions:   Drug: Omega-3 Acid Ethyl Esters;   Drug: Placebo
    Sponsors:   University of Iowa;   GlaxoSmithKline
    Recruiting - verified October 2009
  • Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?

    Condition:   Influenza
    Interventions:   Biological: Fluviral influenza vaccine, 2009-2010;   Biological: Normal saline
    Sponsors:   Mount Sinai Hospital, Canada;   GlaxoSmithKline
    Recruiting - verified November 2009
  • Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

    Conditions:   HIV Infections;   Heart Disease
    Interventions:   Drug: Lovaza;   Drug: Placebo
    Sponsors:   University Hospitals of Cleveland;   The Campbell Foundation;   Case Western Reserve University;   GlaxoSmithKline
    Active, not recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials